Literature DB >> 8195017

Activators of protein kinase C selectively mediate cellular cytotoxicity to hypoxic cells and not aerobic cells.

A C Koong1, E Y Chen, C Y Kim, A J Giaccia.   

Abstract

PURPOSE: By understanding the signal transduction pathways through which a cell responds to changes in environmental oxygen levels, we may be able to therapeutically exploit this response by manipulating these pathways.
MATERIALS AND METHODS: The human adenocarcinoma cell line A549 was exposed to varying durations of hypoxia alone and then plated for survival, or treated with PKC activating agents for 1 h before plating for survival. Western blots were used to determine the kinetics of PKC epsilon and phospholipase C induction.
RESULTS: The level of hypoxic killing was directly related to the time of exposure and inversely related to the level of oxygen in the environment. Exposure of the cells to protein kinase C (PKC) activators for 1 h after chronic hypoxic exposure increased cell killing by at least an additional three logs beyond that found for hypoxia alone. Treatment of cells with an inactive phorbol ester 4 alpha-phorbol-12,13-didecanoate (PDA) resulted in no increase in hypoxic cell killing, even at the highest concentrations of PDA which produced no detectable toxicity under normal aerobic conditions. Using inhibitors of phospholipases A2 and C, we were able to completely inhibit the additional hypoxic cell killing induced by TPA, but not the uninduced hypoxic cell killing.
CONCLUSION: These studies suggest that accumulation of phospholipid breakdown products may be responsible for TPA induced cell killing, and that hypoxic cells differ from aerobic cells in their ability to tolerate these products.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8195017     DOI: 10.1016/0360-3016(94)90272-0

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  2 in total

1.  NFκB and HIF display synergistic behaviour during hypoxic inflammation.

Authors:  Ulrike Bruning; Susan F Fitzpatrick; Till Frank; Marc Birtwistle; Cormac T Taylor; Alex Cheong
Journal:  Cell Mol Life Sci       Date:  2011-11-09       Impact factor: 9.261

Review 2.  Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis.

Authors:  W Kolch; G Martiny-Baron; A Kieser; D Marmé
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.